The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders
Immune cell homoeostasis is attributed to multiple distinct safety valves that are interconnected and intervene at defined checkpoints of the life cycle of immunocytes to guarantee clonal expansion and functional inactivation of self-reactive potentially autoaggressive lymphocytes. Galectins, animal...
Saved in:
Published in: | Annals of the rheumatic diseases Vol. 64; no. suppl 4; pp. iv96 - iv103 |
---|---|
Main Authors: | , , , |
Format: | Journal Article Conference Proceeding |
Language: | English |
Published: |
London
BMJ Publishing Group Ltd and European League Against Rheumatism
01-11-2005
BMJ BMJ Publishing Group LTD |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Immune cell homoeostasis is attributed to multiple distinct safety valves that are interconnected and intervene at defined checkpoints of the life cycle of immunocytes to guarantee clonal expansion and functional inactivation of self-reactive potentially autoaggressive lymphocytes. Galectins, animal lectins defined by shared consensus amino acid sequence and affinity for β-galactose containing oligosaccharides, are found on various cells of the immune system, and their expression is associated with the differentiation and activation status of these cells. Over the past few years, galectins have been implicated in the regulation of many aspects of T cell physiology such as cell activation, differentiation, and apoptosis. In addition, a growing body of experimental evidence indicates that galectins may play critical roles in the modulation of chronic inflammatory disorders, autoimmunity, and cancer. Given the increased interest of immunologists in this field, the growing body of information raised during the past few years and the potential use of galectins as novel anti-inflammatory agents or targets for immunosuppressive drugs, we will summarise recent advances on the role of galectins in different aspects of T cell physiology and their impact in the development and/or resolution of chronic inflammatory disorders, autoimmunity, and cancer. |
---|---|
Bibliography: | PMID:16239398 istex:2F2B51DAEC04AAB500B285A57F006E17ACCE7882 ark:/67375/NVC-DTDV3LP1-6 href:annrheumdis-64-iv96.pdf Correspondence to: Dr G A Rabinovich División Inmunogenética, Hospital de Clínicas “José de San Martín”, Facultad de Medicina, Universidad de Buenos Aires, Av. Córdoba 2351. 3 Piso. (C1120) Ciudad de Buenos Aires, Argentina; gabyrabi@ciudad.com.ar local:0640096 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0003-4967 1468-2060 |
DOI: | 10.1136/ard.2005.044347 |